| 0 (0%) | 09-27 09:29 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 20.97 | 1-year : | 24.5 |
| Resists | First : | 17.95 | Second : | 20.97 |
| Pivot price | 16.83 |
|||
| Supports | First : | 15.29 | Second : | 13.64 |
| MAs | MA(5) : | 17.27 |
MA(20) : | 16.56 |
| MA(100) : | 13.14 |
MA(250) : | 14.88 |
|
| MACD | MACD : | 0.6 |
Signal : | 0.6 |
| %K %D | K(14,3) : | 66.5 |
D(3) : | 73.2 |
| RSI | RSI(14): 60.8 |
|||
| 52-week | High : | 21 | Low : | 9.22 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.[ AXGN ] has closed below upper band by 32.6%. Bollinger Bands are 39.5% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 17.28 - 17.36 | 17.36 - 17.43 |
| Low: | 16.48 - 16.58 | 16.58 - 16.66 |
| Close: | 17.01 - 17.17 | 17.17 - 17.3 |
Thu, 25 Sep 2025
Masimo Completes Divestment of Consumer Audio Business to HARMAN - The Globe and Mail
Wed, 24 Sep 2025
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - FinancialContent
Sat, 20 Sep 2025
Insider Selling: AxoGen (NASDAQ:AXGN) Insider Sells 1,137 Shares of Stock - MarketBeat
Fri, 19 Sep 2025
Acadian Asset Management LLC Boosts Stake in AxoGen, Inc. $AXGN - MarketBeat
Tue, 16 Sep 2025
Insider Sale: Chief Innovation Officer of $AXGN Sells 1,137 Shares - Quiver Quantitative
Fri, 12 Sep 2025
Are Medical Stocks Lagging AxoGen (AXGN) This Year? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 46 (M) |
| Shares Float | 45 (M) |
| Held by Insiders | 4.7 (%) |
| Held by Institutions | 88.4 (%) |
| Shares Short | 2,570 (K) |
| Shares Short P.Month | 4,100 (K) |
| EPS | -0.11 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 2.45 |
| Profit Margin | -2.3 % |
| Operating Margin | 2.9 % |
| Return on Assets (ttm) | 0.5 % |
| Return on Equity (ttm) | -4.5 % |
| Qtrly Rev. Growth | 18.2 % |
| Gross Profit (p.s.) | 3.28 |
| Sales Per Share | 4.41 |
| EBITDA (p.s.) | 0.18 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 7 (M) |
| Levered Free Cash Flow | 6 (M) |
| PE Ratio | -171.6 |
| PEG Ratio | 0 |
| Price to Book value | 7 |
| Price to Sales | 3.88 |
| Price to Cash Flow | 109.8 |
| Dividend | 1 |
| Forward Dividend | 0 |
| Dividend Yield | 5.8% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|